Navigation Links
Nobel laureate to keynote international pharmaceutical conference at URI
Date:6/7/2012

KINGSTON, R.I. June 7, 2012 The University of Rhode Island will hold a global pharmaceutical sciences conference featuring Nobel Prize winner Thomas Steitz from Sept. 28 through 30 at its Kingston Campus.

Steitz, the Sterling Professor of Molecular Biophysics and Biochemistry and professor of chemistry at Yale University, will speak Sunday, Sept. 30 at 9 a.m. Steitz, who was awarded the Nobel Prize for Chemistry in 2009 with two other scientists, is also an investigator at Yale's Howard Hughes Medical Institute.

Registration is required and full details about the conference can be found at http://www.uri.edu/pharmacy/frontiers/2012/index.html. The program is one of many to be held in conjunction with the September grand opening of the new URI College of Pharmacy building, a $75 million facility supported primarily by Rhode Islanders.

Conference co-organizer Navindra Seeram, URI assistant professor of biomedical and pharmaceutical sciences and director of the Bioactive Botanical Research Laboratory, said he believes this will be the largest conference of its kind in the history of the University.

"The Northeast Corridor of the United States is the center of pharmaceutical science research and industry and so this is an ideal location for a program of this type," Seeram said. "The participation of some of the world's leading biomedical scientists, including Yale's Professor Steitz, is an indication of the high regard they have for research going on at URI's College of Pharmacy and, indeed, the ongoing scientific work of many of our colleges. We have attracted renowned scientists from every portion of the globe, including researchers in India and Pakistan who have partnerships with us."

Conference co-organizer Keykavous Parang, URI professor of medicinal chemistry and pharmacology, said the conference will offer one of the most diverse groups of speakers for events of this type.

"If you are a scientist, researcher educator, or student in the area of drug discovery and development, you don't want to miss this opportunity to learn and network with some of most prominent names in the field," Parang said.

The deadline for submission of abstract is June 29. To submit your abstract, please visit: http://www.uri.edu/pharmacy/frontiers/2012/abstract_submission.html.

The program will focus on the latest in bench drug discovery (natural products, medicinal chemistry and biologics) and drug development stages (delivery, nanotechnology, toxicology, clinical pharmacology, drug metabolism, transporters and pharmacokinetics).

Other keynote speakers will be: Chad A. Mirkin, professor of materials science and engineering and director of the International Institute for Nanotechnology at Northwestern University; Tej P. Singh, professor of biophysics at the All India Institute of Medical Sciences; Jhillu Singh Yadav, director of the Indian Institute of Chemical Technology; and Christopher Walsh, the Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. In addition, leading researchers from Canada, China, Germany, Japan, Pakistan, South Korea, Spain, Sweden, and the United Kingdom will all speak.

Steitz's talk is titled "From the Structure and Function of the Ribosome to New Antibiotics." A ribosome is a small particle containing ribonucleic acid in a cell that is a site for protein synthesis.

Steitz's short biographical sketch hardly does justice to a man who links his public school shop classes and his brother's academic excellence to his great successes in the laboratory.

In addition to the Nobel Prize in 2009, Steitz was presented the Gairdner International Award in 2007, Keio Medical Science Prize in 2006, the AAAS Newcomb Cleveland Prize in 2001, the Rosenstiel Award for Distinguished Work in Basic Medical Research in 2001, and the Pfizer Award in Enzyme Chemistry in 1980. He has been a member of the National Academy of Sciences since 1990.

A faculty member at Yale since 1970, Steitz was a Fairchild Scholar at the California Institute of Technology from 1984 to 1985 and a Macy Fellow in Gottingen, Germany, from 1976 to 1977. He earned his doctorate at Harvard University in 1966.


'/>"/>

Contact: Dave Lavallee
dlavallee@advance.uri.edu
401-874-5862
University of Rhode Island
Source:Eurekalert

Related medicine news :

1. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
2. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
3. Kessler Foundation researchers present at first International Congress on Cognition in MS
4. International conference to explore health of descendants of transatlantic slave trade
5. International breast health global summit will focus on supportive care and quality of life
6. MSU invention could help pharmaceutical industry save money
7. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
8. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
9. Blending conference translates substance abuse research into practice
10. NJ stroke researchers report advances in spatial neglect research at AAN Conference
11. Elsevier organizes label-free technologies conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: